Compare ALT & MGPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALT | MGPI |
|---|---|---|
| Founded | 1997 | 1941 |
| Country | United States | United States |
| Employees | N/A | 267 |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.5M | 392.6M |
| IPO Year | 2005 | 1994 |
| Metric | ALT | MGPI |
|---|---|---|
| Price | $2.81 | $18.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | $17.67 | ★ $28.75 |
| AVG Volume (30 Days) | ★ 4.6M | 219.6K |
| Earning Date | 05-08-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.50% |
| EPS Growth | ★ 25.37 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $41,000.00 | ★ $19,782,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.11 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 105.00 | N/A |
| 52 Week Low | $2.56 | $15.72 |
| 52 Week High | $6.44 | $32.60 |
| Indicator | ALT | MGPI |
|---|---|---|
| Relative Strength Index (RSI) | 43.00 | 58.62 |
| Support Level | $2.72 | $17.56 |
| Resistance Level | $3.09 | $18.31 |
| Average True Range (ATR) | 0.14 | 0.74 |
| MACD | -0.03 | 0.17 |
| Stochastic Oscillator | 8.41 | 83.32 |
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
MGP Ingredients Inc is a producer and supplier of distilled spirits, specialty wheat protein, and starch food ingredients based in the United States. It operates in three reportable segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Maximum revenue is generated from the Branded Spirits segment, which consists of a portfolio of brands that it produces through its distilleries and bottling facilities and sells to distributors or to state governments that directly control the sale of alcohol. MGP's branded spirits include various brands across numerous categories and price tiers, such as Penelope Bourbon, Yellowstone Bourbon, Minor Case Straight Rye Whiskey, Brady's Irish Cream, Exotico Tequila, Arrow Cordials, Canada House Canadian Whisky, Lady Bligh Rum, etc.